2023 North America Conference on Lung Cancer (NACLC) - Posters and Abstracts-PP01.060 Vershalee Shukla NACLC23 Abstract

PP01.060 Vershalee Shukla NACLC23 Abstract

Pdf Summary

The study evaluates the use of Nodify Lung Testing in assessing the risk of malignancy in lung nodules among a group of first responders who are at high risk for developing lung cancer due to occupational exposure. The retrospective review included 40 first responders, with an average age of 49 years. The majority of patients were male and non-smokers, with no history of cancer. The size of the nodules ranged from 10mm to 15mm. The Pre-Test Risk Assessment indicated that 80% of the nodules had a low risk of malignancy, while 2.5% had a high risk. After conducting the Nodify Lung Testing, 95% of the nodules were classified as likely benign, 2.5% as having a moderate risk of malignancy, and another 2.5% as having a high risk. There was a significant risk change observed in 17.5% of the nodules. One patient with a Pre-Test score of 4% had their risk increase to 37% and required further testing with a PET-CT scan. The study concludes that Nodify Lung Testing is beneficial in determining the risk of malignancy in lung nodules, with 27.5% of the nodules being reclassified. This testing method helps differentiate benign from malignant nodules, improves patient compliance, reduces the need for further testing with CT scans, and alleviates patient anxiety during the follow-up period. Nodify Lung Testing can be useful, especially in the surveillance of lung nodules among high-risk individuals like first responders. The first responders in the study had a positive response to Nodify Lung Testing, and it will continue to be used in their program.

Keywords

Nodify Lung Testing

risk assessment

malignancy

lung nodules

first responders

occupational exposure

retrospective review

nodules size

benign nodules

malignant nodules